← All organizations
Highest phase reached
Phase 4
First clinical trial
Nov 26, 2019Last known activity
Jan 1, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (6 distinct, 6 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Other trials (4 own, 0 via acquisition)
Recent trials (11)
- NCT06411028CollaboratorPhase 4Jan 1, 2025
- NCT05477459CollaboratorPhase 2May 31, 2023
- NCT05675007Lead sponsorN/ADec 5, 2022
- NCT05785429Overall official - principal investigatorN/AAug 2, 2022
- NCT05785429Lead sponsorN/AAug 2, 2022
- NCT05884671Lead sponsorN/ASep 23, 2021
- NCT05884671Reponsible party - principal investigatorN/ASep 23, 2021
- NCT05884671Sponsor investigatorN/ASep 23, 2021
- NCT05272397Lead sponsorN/ANov 26, 2019
- NCT05272397OfficialN/ANov 26, 2019
- NCT05272397Overall official - principal investigatorN/ANov 26, 2019
Details
- Last known activity
- Jan 1, 2025